Pharmacology and Toxicology
-
Human ACE2 peptide mimics block SARS-CoV-2 Pulmonary Cells Infection
This article has 9 authors:Reviewed by ScreenIT
-
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
This article has 6 authors:Reviewed by ScreenIT
-
Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase
This article has 9 authors:Reviewed by ScreenIT
-
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
This article has 17 authors:Reviewed by ScreenIT
-
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
This article has 16 authors:Reviewed by ScreenIT
-
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
This article has 6 authors:Reviewed by ScreenIT
-
In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
Pharmacokinetics of Orally Administered GS-441524 in Dogs
This article has 13 authors:Reviewed by ScreenIT
-
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2
This article has 3 authors:Reviewed by ScreenIT
-
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
This article has 12 authors:Reviewed by ScreenIT